Contributions of Hyperactive Mutations in M(pro) from SARS-CoV-2 to Drug Resistance
Description
The appearance and spread of mutations that cause drug resistance in rapidly evolving diseases, including infections by the SARS-CoV-2 virus, are major concerns for human health. Many drugs target enzymes, and resistance-conferring mutations impact
